Imperial College, London

London W6 8RP

6 studies enrolling now · 27 studies all time

What they study most

Acute Myocardial Infarction, Adult Acute Myeloid Leukemia, Advanced Solid Tumor, Advanced Solid Tumors, Advanced Squamous Non-Small Cell Lung Carcinoma, Anemia, Brain Injury, COVID-19 Pneumonia, Cardiovascular Diseases, Cardiovascular Morbidity, Complete Response, Coronary Artery Disease

Studies at this site

• A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort — Recruiting now
• A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors — Recruiting now
• Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT — Recruiting now
• Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors — Recruiting now
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia — Recruiting now
• Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) — Running, not enrolling
• A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight — Running, not enrolling
• Olorofim Aspergillus Infection Study — Running, not enrolling
• Research Study on Whether a Combination of 2 Medicines (NNC0194 0499 and Semaglutide) Works in People With Non-alcoholic Steatohepatitis (NASH) — Completed
• A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy — Running, not enrolling
• Prospective Research in Infants With Mild Encephalopathy — Completed
• Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity — Completed
• Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients — Completed
• Observational Study of Cardiovascular Disease. — Stopped early
• Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression — Completed
• Efficacy Evaluation of TheraSphere in Patients With Inoperable Liver Cancer — Completed
• A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence — Completed
• Optimising the Duration of Cooling in Mild Encephalopathy — Status unconfirmed
• RBN-2397 in Combination With Pembrolizumab in Patients With SCCL — Status unconfirmed
• Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack — Completed
• A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome — Stopped early
• Functional Lesion Assessment of Intermediate Stenosis to Guide Revascularisation — Status unconfirmed
• Study of Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older With the G551D Mutation — Completed